Pulse Steroid Injection in Refractory Rheumatoid Arthritis

Launched by SOHAG UNIVERSITY · Jun 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called Pulse Steroid Injection for people with active rheumatoid arthritis who have not responded well to other therapies. The goal is to see if this new approach can help participants achieve remission, which means their disease symptoms are greatly reduced or completely disappear, or maintain low disease activity, where the symptoms are manageable.

To participate in this trial, individuals must have rheumatoid arthritis that hasn't improved despite other treatments. It is important to note that people with other connective tissue diseases or certain hormonal disorders like diabetes or thyroid problems cannot join. Those who are eligible will receive the Pulse Steroid Injection and will be closely monitored throughout the study to track their progress and any side effects. This trial is currently recruiting participants of all ages, so if you or someone you know is struggling with rheumatoid arthritis, this might be an opportunity to explore a new treatment option.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Refractory rheumatoid arthritis patients
• Exclusion Criteria:
• • Other connective tissue diseases
• • Endocrine diseases such as DM and thyroid disorders